Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 312.90
-4.10 (-1.29%)
Aug 28, 2026, 4:59 PM CET
Zealand Pharma Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Zealand Pharma stock has a consensus rating of "Buy" and an average price target of kr 440.14. The average 1-year stock price forecast is 40.66% higher than the current stock price, while the lowest is kr 300.00 (-4.12%) and the highest is kr 745.00 (+138.10%).
Price Target: kr 440.14 (+40.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zealand Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 6 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 | 7 | 8 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Financial Forecast
Revenue This Year
4.84B
from 9.21B
Decreased by -47.45%
Revenue Next Year
4.16B
from 4.84B
Decreased by -14.01%
EPS This Year
25.06
from 90.22
Decreased by -72.22%
EPS Next Year
6.78
from 25.06
Decreased by -72.95%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.